Evidence map›Paper›PMID 37426342›Full record

ArticleiScience2023

Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson's iPSC-dopamine neurons.

Dayne A Beccano-Kelly, Marta Cherubini, Yassine Mousba, Kaitlyn M L Cramb, Stefania Giussani, Maria Claudia Caiazza, Pavandeep Rai, Siv Vingill, Nora Bengoa-Vergniory, Bryan Ng and 5 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Frontiers in neuroscience · 2025
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Dayne A Beccano-KellyOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Marta CherubiniOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Yassine MousbaOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Kaitlyn M L CrambOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Stefania GiussaniOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Maria Claudia CaiazzaOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Pavandeep RaiOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Siv VingillOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Nora Bengoa-VergnioryOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Bryan NgDepartment of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX3 7BN, UK.
Gabriele CordaDepartment of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX3 7BN, UK.
Abhirup BanerjeeRadcliffe Department of Medicine, Division of Cardiovascular Medicine, University of Oxford, Oxford OX3 9DU, UK.
Jane VowlesOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Sally CowleyOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
Richard Wade-MartinsOxford Parkinson's Disease Centre, University of Oxford, Oxford, United Kingdom.
University of Oxford · GB

Funding

Medical Research Council MR/N029453/1Medical Research Council MR/T041129/1
6 · The paper itself

Abstract

Parkinson's disease (PD) is characterized by a progressive deterioration of motor and cognitive functions. Although death of dopamine neurons is the hallmark pathology of PD, this is a late-stage disease process preceded by neuronal dysfunction. Here we describe early physiological perturbations in patient-derived induced pluripotent stem cell (iPSC)-dopamine neurons carrying the

Indexed as

Cellular neurosciencePathophysiologyStem cells research

Identifiers

PMID37426342
PMCPMC10329047
OpenAlexW4379745375

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.